Apneic Oxygenation
Conditions
Brief summary
The study will test the efficacy of the Pentax AWSTM video laryngoscope (VLS) equipped with a P Blade (Figure 1) as the means to provide Apneic Oxygenation (AO) and prolong Duration of Apnea Without Desaturation (DAWD) in non-obese and morbidly obese females.
Detailed description
Pre-oxygenation/de-nitrogenation for three minutes of spontaneous breathing or alternatively four to eight deep breaths prior to rapid sequence anesthetic induction/intubation (RSII) in patients with healthy lungs, low oxygen demands and normal hemoglobin levels allows up to eight minutes of safe apnea time or DAWD. The study will test the efficacy of the Pentax AWSTM video laryngoscope (VLS) equipped with a P Blade as the means to provide apneic oxygenation and prolong DAWD. The P Blade sports a suction conduit which can equally well provide a conduit for oxygen administration. The initial phase of the study will include non-obese healthy (ASAR 1-2) women patients requiring endotracheal anesthesia for gynecologic (open or laparoscopic) abdominal surgery. Subsequently a cohort of morbidly obese patients (BM I ≥ 40 kg/m2) also requiring gynecologic abdominal access will be recruited for investigation. Participants of each group (obese, non-obese) will be randomized to apneic oxygenation with the the Pentax AWS Laryngoscope or no apneic oxygenation.
Interventions
DEVICEApneic oxygenation: Eight minute
A Pentax AWSTM video laryngoscope with attached P blade will be placed and then 10 l/minute flow of oxygen will be administered through the P blade (apneic oxygenation) for eight minutes, or less if SpO2 falls to ≤ 95%. The trachea will then be intubated and the ventilation of the lungs will commence using 100% oxygen until SpO2 ≥ 98%.
DEVICEWithout apneic oxygenation
A Pentax AWSTM video laryngoscope with attached P blade will be placed for eight minutes, or less if SpO2 falls to ≤ 95%. The trachea will then be intubated and the ventilation of the lungs will commence using 100% oxygen until SpO2 ≥ 98%.
DEVICEApneic oxygenation: five minutes
A Pentax AWSTM video laryngoscope with attached P blade will be placed and then 10 l/minute flow of oxygen will be administered through the P blade (apneic oxygenation) for five minutes, or less if SpO2 falls to ≤ 95%. The trachea will then be intubated and the ventilation of the lungs will commence using 100% oxygen until SpO2 ≥ 98%.
Sponsors
Vanderbilt University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Female patients, 2. American Society of Anesthesiologists Rating 1-2, 3. Aged 18 through 65 years of age 4. Elective gynecological surgery via an abdominal approach (laparoscopic or open) 5. Already consented to general anesthesia necessitating endotracheal intubation. 6. Are candidates for anesthesia using laryngeal mask airway if needed
Exclusion criteria
1. Patient refusal to enter study 2. History of difficult mask ventilation 3. History of, or anticipated difficult intubation 4. Heavy Smokers (\> 10 cigarettes per day) 5. Asthma 6. Chronic Obstructive Pulmonary Disease 7. Heart Disease 8. Renal or Liver disease 9. Neurological disease. 10. Women scored at ≥ 3/4 on the modified Mallampati scale 30. 11. Women exhibiting other signs of a potential difficult intubation (limited neck flexion or extension; neck circumference \> 30 cm; prominent incisors) 12. Patients with a baseline resting oxygenation level of less than 95%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of apnea without desaturation | Time in seconds from the initiation of laryngoscopy until the time at which Sp02 falls to 95%, or until 8 minutes have elapsed |
Outcome results
None listed